← FDA Drug Approvals (Drugs@FDA)

RITONAVIR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2022-05-10

Drug application

FDA Application #

ANDA203759

Application type

Abbreviated New Drug Application (Generic)

Brand name

RITONAVIR

Generic name

Ritonavir

Active ingredients

RITONAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

First approval

2022-05-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown